{
  "image_filename": "table_p2_det_1_019.png",
  "image_path": "FlublokPI/extracted/figures/table_p2_det_1_019.png",
  "image_type": "Table",
  "page_number": 2,
  "block_id": "det_1_019",
  "claim_id": "claim_005",
  "claim": "Flublok (quadrivalent) was evaluated in the pivotal trial against Fluarix (quadrivalent standard-dose vaccine).",
  "supports_claim": false,
  "explanation": "A table displaying percentages of solicited adverse events (local and systemic) by severity (any, moderate, severe) across multiple study groups, with footnotes referencing Studies 2 and 4 and U.S.-licensed IIV3 vaccines. The table does not mention Flublok quadrivalent or Fluarix quadrivalent standard-dose vaccine and instead shows reactogenicity data without specifying those vaccines, so it does not support the claim. Note: Image is a partial screenshot of a table; vaccine names and study arms may be truncated or off-screen.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "A table displaying percentages of solicited adverse events (local and systemic) by severity (any, moderate, severe) across multiple study groups, with footnotes referencing Studies 2 and 4 and U.S.-licensed IIV3 vaccines.",
    "evidence_found": null,
    "reasoning": "The table does not mention Flublok quadrivalent or Fluarix quadrivalent standard-dose vaccine and instead shows reactogenicity data without specifying those vaccines, so it does not support the claim.",
    "confidence_notes": "Image is a partial screenshot of a table; vaccine names and study arms may be truncated or off-screen."
  }
}